Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Pharmaceutical Executive April 1, 2009 Jill Wechsler	Kickoff for Reform In addition to overhauling healthcare, Congress is weighing proposals for updating FDA policies and expanding access to drugs.
Investment Advisor July 2009 Melanie Waddell	The Great Health Reform Debate President Barack Obama has set an ambitious deadline of October to achieve comprehensive healthcare reform.
The Motley Fool December 1, 2008 Brian Orelli	Health Insurers' Universal Uncertainty Universal health care is putting a damper on insurers.
The Motley Fool January 28, 2010 Brian Orelli	Health-Care Reform Is Dead. Probably. Breaking up the bill doesn't seem like the answer. What do insurers and pharmaceutical companies have to say?
The Motley Fool May 12, 2009 Brian Orelli	Your Company Is Giving Away Revenue Bad news for investors in the health-care industry: the companies you invest in just pledged to give back 1.5% of their expected U.S. revenue growth to President Obama.
The Motley Fool July 31, 2009 Brian Orelli	A Health-Care Investor's Nightmare When it comes to health-care reform, no news is not good news; the House's recent plan to delay voting on a health-care reform bill until September should have investors reaching for the antacids.
The Motley Fool November 7, 2008 Brian Orelli	Will Obama Make Your Portfolio Healthy? The changes coming in the health-care industry could be a mixed bag of good and bad for your portfolio.
The Motley Fool March 22, 2010 Brian Orelli	Health-Care Reform Passes! Here's Where to Invest Now Some healthy suggestions for your portfolio.
The Motley Fool January 14, 2010 Jim Mueller	Roundtable: Which Health-Care Stocks to Buy Now Three Fool analysts give you their best ideas on where to put your money after the health-care reform bill makes it out of Congress.
The Motley Fool April 6, 2009 Michael P. Cecil	Investing in Pharma? Remember Rule No. 1 Health care reform is likely this year. How will that affect your pharma investments?
Pharmaceutical Executive December 1, 2008 Jill Wechsler	Challenge and Challenges Expanded healthcare coverage also fits the goals of pharma manufacturers.
The Motley Fool January 26, 2011 Brian Orelli	Health-Care Reform Lives: Here's Where to Invest State of the Union turned investment thesis regarding health insurance companies.
The Motley Fool February 27, 2009 Brian Orelli	Can $634 Billion Save the U.S. Health Care System? The good news is that Obama's budget includes a $634 billion down payment on getting insurance for the 48 million uninsured. The bad news is that the president has to pay for that by cutting costs in other areas.
Chemistry World March 25, 2010 Rebecca Trager	Big pharma scores in US healthcare reform President Obama has signed the biggest US healthcare reform since the 1960s, and although it is largely seen as a victory for the pharmaceutical industry, some analysts are characterising it as a 'double-edged sword'.
The Motley Fool September 17, 2009 Brian Orelli	Baucuscare: Who's Paying? You are -- indirectly, of course. But nobody said reform would be cheap.
The Motley Fool April 22, 2009 Selena Maranjian	Will Health-Care Reform Hurt Investors? The bad news here is that there's quite a bit of uncertainty around this issue, and that some health-care-focused companies may end up suffering. Read on to see who.
The Motley Fool April 7, 2009 Brian Orelli	Thanks for Nothing, CMS Insurers like Humana, Coventry Health Care, and UnitedHealth Group are going to have to raise the prices of their Medicare Advantage plans to keep their margins at a reasonable level.
The Motley Fool April 14, 2011 Morgan Housel	What You Need to Know About the President's Plan to Save $4 Trillion President Barack Obama laid out a plan to slash $4 trillion from the deficit between now and 2023. Here's roughly how it'll get done.
Pharmaceutical Executive December 1, 2012 Jill Wechsler	Obamacare, Innovation and Pricing Tax and budget decisions will shape the healthcare market and drug research and regulation.
Investment Advisor October 2009 Melanie Waddell	Danger & Opportunity: Healthcare Reform Picks Up Momentum Healthcare reform is still moving ahead, despite opposition from Republicans and well-covered populist discontent over the plan.
The Motley Fool February 12, 2009 Brian Orelli	Stimulus Could Be Bitter Pill for Some Investors Health-care shareholders need to watch provisions of the stimulus bill closely.
The Motley Fool September 20, 2007 Brian Orelli	Winners and Losers in Universal Health Care Here's a look at the companies that stand to win or lose if Hillary Rodham Clinton is elected -- and gets her three-pronged health-care reform plan through Congress.
The Motley Fool May 16, 2011 Dan Caplinger	Don't Let This Kill Your Retirement Social Security and Medicare look sick. Here's how to handle it.
Pharmaceutical Executive April 1, 2011	Revisiting Reform Courts, Congress review policies and programs shaping drug costs and access.
The Motley Fool March 12, 2010 Brian Orelli	Insurers to Washington: We're Not the Problem Insurers say they're a small piece of the problem pie.
Managed Care July 2002	Memo Clarifies CMS Guidelines on Injectables Injectable drugs should be covered by Medicare if beneficiaries administer them less than 50 percent of the time, according to a clarification on this issue by the Centers for Medicare and Medicaid services that's set to take effect Aug. 1.
CFO October 1, 2009 Alix Stuart	Waiting and Wondering While it's not yet known exactly what health-care reform will look like, it's even less clear what the impact on company finances will be.
The Motley Fool May 18, 2009 Dan Caplinger	The Biggest Threat Your Retirement Has Ever Faced The government released reports about the failing prospects for Social Security and Medicare -- a failure that could fundamentally change the way you have to survive in retirement.
The Motley Fool May 31, 2011 Brian Orelli	Profit From This Growing Drug Trend Cancer drugs press on.
The Motley Fool February 9, 2010 Brian Orelli	What Bipartisan Health-Care Reform Means for Investors Republicans and Democrats will debate on TV, but little may come of it.
The Motley Fool August 26, 2009 Brian Orelli	Could Health-Care Reform Fix Your Sick Portfolio? For the health care sector there may be no greater unknown today than the final shape of health-care reform legislation.
BusinessWeek May 20, 2009 Maria Bartiromo	Pfizer's Kindler on Health-Care Reform and the Wyeth Deal Pfizer's CEO discusses its acquisition of Wyeth and its plan to provide some drugs for free to those without jobs and insurance.
The Motley Fool August 26, 2010 Brian Orelli	Drug Prices Up, but Don't Read Too Much Into It AARP is out with its annual report on the cost of medications, and it's more of the same: bad news if you're a consumer, but good news if you're invested in drugmakers.
Pharmaceutical Executive December 1, 2010 Jill Wechsler	New Ballgame in Washington Republican gains in Congress create uncertainty for health reform, drug regulation, and biomedical research
Searcher October 2010 Stephanie C. Ardito	The Medical Digital: U.S. Healthcare Reform: A Follow-Up For those interested in serious, scholarly research regarding the historical progress of U.S. healthcare reform, this column and my prior column might be a good pairing for neutral sources.
Insurance & Technology March 26, 2010 Anthony O'Donnell	Fidel Castro Applauds US Healthcare Reform Castro calls reform a "miracle" and a victory over "lobbyists and political mercenaries," in qualified praise of President Obama, whom he calls a "fanatical believer in the imperialist capitalist system."
The Motley Fool March 25, 2009 Brian Orelli	You Can't Have One Without the Other Heath insurers are playing fair.
BusinessWeek August 6, 2009	Health Reform: A Timeline The latest battle over how to overhaul the U.S. health-care system intensified last fall with the election of Barack Obama.
Knowledge@Wharton	Prescription Drug Coverage for Seniors Faces Uncertain Future The discussion about adding a prescription drug benefit to Medicare will be put on hold...
The Motley Fool March 30, 2010 Brian Orelli	Your Biotech's Cash Burn Just Went Down Tucked inside the hundreds of pages of the health-care reform bill, is a nice little bonus for a select group of drugmakers.
The Motley Fool February 25, 2010 Brian Orelli	An Untouched Market Waiting to Be Captured Unfilled prescriptions are a potential boon to drug companies.
The Motley Fool December 30, 2010 Brian Orelli	This NICE Deal Could Foreshadow 2011 Value-based pricing is coming. The only way to encourage lower drug costs is to get the end user to pay the cost directly.
The Motley Fool September 17, 2009 Charly Travers	Companies That Will Thrive Under Obamacare They are out there.
Pharmaceutical Executive January 1, 2013 Jill Wechsler	Transformation to Characterize 2013 FDA policies will reshape drug development, while pressure to cut healthcare spending may alter drug coverage and pricing.
The Motley Fool May 28, 2009 Brian Orelli	When All Else Fails Save the customer money so they can give it to you.
The Motley Fool December 3, 2009 Brian Orelli	Health-Care Reform Is Very Taxing On the industries that keep us alive.
The Motley Fool September 10, 2009 Brian Orelli	Obamacare: Something for Everyone to Hate Health insurers saw more to love, though.
Managed Care July 2000 Michael Levin-Epstein	Congress Asked To Take Action As HMOs Flee Managed Medicare Thanks mainly to the increasing cost of providing a prescription drug benefit, HMOs are exiting Medicare+Choice, the system that was supposed to manage the health of the nation's senior citizens, in droves. Only an act of Congress can save Medicare+Choice, but is seems doubtful that will happen.
The Motley Fool September 23, 2009 Brian Orelli	Witch Hunt, Round 2? Humana mails Medicare Advantage members about health-care reform, and not everyone approves.
BusinessWeek October 22, 2009 Sasseen & Arnst	Who Picks Up the Tab for Health Reform Insurers and taxpayers are likely to pay big chunks of the $900 billion bill to overhaul the nation's health-care system. Doctors will feel the least pain.